SITO Mobile Receives Two New Streaming Patents

Press Releases |

JERSEY CITY, N.J., Sept. 29, 2015 -- SITO Mobile Ltd. (SITO) , a leading mobile engagement platform provider, today announced that its subsidiary SITO Mobile R&D IP, LLC has been granted two patents, U.S. Patent Nos. 9,135,635 and 9,135,636, both titled "System and Method for Routing Media," by the U.S. Patent and Trademark Office.

Jerry Hug, Chief Executive Officer of SITO Mobile said, "Our dedication to driving shareholder value lies in our ability to generate growth for the Company and strengthen our IP portfolio. We are pleased to receive these patents and will continue to seek new U.S. patent recognition for SITO's technology innovations in this commercially vibrant space."

The two patents issued on September 15, 2015 bring the total number of U.S. patents in this SITO Mobile patent family to nine, with several pending applications designed to add value to SITO Mobile's overall intellectual property portfolio. SITO's IP Portfolio encompasses over twenty U.S. patents that include innovation and IP coverage in the areas of mobile device applications, mobile marketing, streaming media and dynamic ad insertion.

About SITO Mobile Ltd.

SITO Mobile provides a mobile engagement platform that enables brands to increase awareness, loyalty, and ultimately sales. For more information visit

Forward-Looking Statements

This press release contains "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, our reliance on brand owners and wireless carriers, the possible need for additional capital as well other risks identified in our filings with the SEC. Any forward-looking statement made by us in this press release is based only on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.

Investor Relations:
Robert Haag
IRTH Communications



DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Symbol Name Price Change % Volume
SITO SITO Mobile Ltd. 5.01 -0.09 -1.76 76,921


Emerging Growth

Sack Lunch Productions Inc

Sack Lunch Productions Inc is an entertainment company. The Company, through its subsidiaries, is engaged in event management, production service, film production and distribution services.

Private Markets

MyForce, Inc.

As parents, we constantly worry about the safety of our loved ones. The media bombards us with incidents from across the nation school shootings, frequent assaults on campuses, and crimes…

BioSculpture Technology, Inc.

BioSculpture Technology, Inc. (“BST”) is a commercial-stage medical device manufacturer of liposuction surgical instruments for surgeons. It offers the FDA-cleared Twin Cannula Assisted Liposuction ("TCAL") Airbrush Liposculptor II® controllers, Airbrush®…